TACN vs VXUS
T. Rowe Price Active Core International Equity ETF vs Vanguard Total International Stock ETF
Which is better, TACN or VXUS?
TACN costs less.
TACN has a lower expense ratio.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | TACN | VXUS |
|---|---|---|
| Expense Ratio | 0.00%Best | 0.05% |
| AUM | $24M | $163.2B |
| Dividend Yield | 0.00% | 2.34% |
| Holdings | 502 | 8,844 |
| YTD Return | +8.55% | +10.00%Best |
| 1Y Return | - | +17.01% |
| 3Y Return (annualized) | - | +19.55% |
| 5Y Return (annualized) | - | +8.55% |
| Fund Family | T.Rowe Price | Vanguard (US) |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Blend |
| Inception | Dec 10, 2025 | Jan 26, 2011 |
Not shown on this pair: Volatility (annualized), Max Drawdown, $10,000 over the window, Top 10 Weight.
TACN vs VXUS growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view is available from the range buttons; it is not the opening view here because over the whole period one of these two funds moves so much further than the other that its line would sit flat on the axis.
TACN vs VXUS Performance
T. Rowe Price Active Core International Equity ETF (TACN) is an ETF from T.Rowe Price and Vanguard Total International Stock ETF (VXUS) is an ETF from Vanguard (US). Year to date, TACN is up 8.55% versus a gain of 10.00% for VXUS.
Past performance does not guarantee future results.
Fees and Cost Over Time
TACN charges 0.00% per year while VXUS charges 0.05%. On a $10,000 position that is $0 vs $5 annually, a gap of $5 per year that compounds over a long holding period. On income, TACN currently yields 0.00% against 2.34% for VXUS.
Holdings Overlap
At least 74.7% of TACN's money is in holdings VXUS also owns.
Stated as a floor: for VXUS, our book for it covers 91.3% of that fund, so a holding it does not list is one we cannot count as shared. The real figure is this or higher.
Most of TACN is already inside VXUS. Owning both mostly buys the same companies twice.
371 positions in common, counted across the 495 positions we hold weights for in TACN and 8,425 in VXUS, against full books of 502 and 8,844.
Top Shared Holdings
| Stock | Weight in TACN | Weight in VXUS | Difference |
|---|---|---|---|
| ASML:ASASML HOLDING NV | 3.59% | 1.42% | 2.17% |
| HSBA:LNHsbc Holdings Plc | 1.45% | 0.77% | 0.68% |
| NOVN:SMNovartis Ag – Class N | 1.16% | 0.62% | 0.54% |
| SIE:SGSiemens Ag Reg Common Stock | 1.01% | 0.53% | 0.48% |
| AZN:LNAstraZeneca PLC | 1.01% | 0.53% | 0.48% |
| 6098:JPRecruit Holdings Co. Ltd. Com Stk | 1.15% | 0.33% | 0.82% |
| NESN:SMNestle Sa Reg Common Stock Chf.1 | 0.93% | 0.55% | 0.38% |
| ALV:SGAllianz | 1.02% | 0.43% | 0.59% |
| BBVA:MABanco Bilbao Vizcaya Argentaria S.A. Reg Shs | 1.09% | 0.35% | 0.74% |
| 8316:JPSumitomo Mitsui Financial Group Inc. Shs | 1.03% | 0.34% | 0.69% |
74.7% of TACN is already inside VXUS.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, TACN or VXUS?
TACN has an expense ratio of 0.00% while VXUS charges 0.05%. TACN is the cheaper option, by $5 a year on a $10,000 investment.
What is the holdings overlap between TACN and VXUS?
At least 74.7% of TACN's money is in holdings VXUS also owns. Our book for VXUS is partial, so the real figure is this or higher. They hold 371 positions in common, counted across the 495 positions we hold weights for in TACN and 8,425 in VXUS.
Which pays a higher dividend, TACN or VXUS?
TACN yields 0.00% while VXUS yields 2.34%, so VXUS currently pays the higher dividend yield.
Is VXUS better than TACN?
TACN has a lower expense ratio. Which one suits a particular account depends on what it is for. This is information, not a recommendation.